Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04508140
Title Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasis
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Highlight Therapeutics
Age Groups: adult | senior
Covered Countries ITA | ESP | BEL

No variant requirements are available.